MDM2 and glioblastoma: Upon comparing the glioblastoma (GBM) high- and low-expression groups for MDM2, the high-expression group was found to be approximately 50-fold more sensitive to RSL3-induced ferroptosis in cancer cells than the MDM2 low-expression group.